Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,809 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03353831 | Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer | completed | Phase 3 | 574 | AGO Research GmbHINDUSTRY | 12 | Apr 6, 2025 | clinicaltrials |
| NCT03768349 | PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer | completed | Early Phase 1 | 250 | Mayo ClinicOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04188652 |
| Diagnosing Ovarian Cysts - the DOC Study |
| completed |
| — |
| 1,123 |
| Rigshospitalet, DenmarkOTHER |
| 1 |
| Apr 6, 2025 |
| clinicaltrials |
| NCT03654638 | Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer | completed | Phase 2 | 25 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | completed | Phase 1 | 269 | ExelixisINDUSTRY | 9 | Apr 4, 2025 | clinicaltrials |
| NCT06182332 | An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care | completed | N/A | 221 | Mayo ClinicOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT03668652 | Focal Prostate Ablation Versus Radical Prostatectomy(FARP) | completed | N/A | 213 | Oslo University HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT04917744 | Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors | completed | — | 5 | Mayo ClinicOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT03894618 | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 49 | Shattuck Labs, Inc.INDUSTRY | 4 | Apr 2, 2025 | clinicaltrials |
| NCT03749707 | HPV in Sentinel Lymph Nodes of Cervical Cancer Patients | completed | N/A | 127 | University of AarhusOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06377683 | Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 8 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT04600336 | Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer | completed | Phase 2 | 88 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT04697264 | Adipocytokines in Endometrial Cancer | completed | — | 100 | University of SurreyOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT00513786 | Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma | completed | Phase 2 | 38 | David O'MalleyOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT03093428 | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | completed | Phase 2 | 45 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT05210556 | Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery | completed | — | 778 | WellSpan HealthOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT05257057 | Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome | completed | — | 91 | WellSpan HealthOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT05796518 | Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors | completed | N/A | 44 | Wake Forest University Health SciencesOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT02922764 | A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer | completed | Phase 1 | 146 | Inspirna, Inc.INDUSTRY | 1 | Mar 26, 2025 | clinicaltrials |
| NCT04696276 | Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece(ERAS) | completed | N/A | 101 | University of West AtticaOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06897306 | Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study | completed | — | 317 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT03087903 | A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA | completed | N/A | 41 | University of Colorado, DenverOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT04049747 | Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer(IP4-CHRONOS) | completed | N/A | 100 | Imperial College LondonOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT05137067 | A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents. | completed | Phase 2 | 90 | Optimal Health ResearchOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06883474 | Osteosclerotic Changes on CT Predict Survival in Prostate Cancer | completed | — | 211 | Sun Yat-sen UniversityOTHER | 0 | Mar 21, 2025 | clinicaltrials |
| NCT00638898 | Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05666947 | Effectiveness of Two Exercises in Preventing Lower-Limb Lymphedema After Gynecological Cancer Surgery | completed | N/A | 60 | Yu-Yun HsuOTHER | 0 | Mar 20, 2025 | clinicaltrials |
| NCT06599463 | Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Multicentric Retrospective Early Access Program-based Study(LARENA) | completed | — | 351 | ARCAGY/ GINECO GROUPOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT02420977 | Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer | completed | Early Phase 1 | 23 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT02649790 | Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications | completed | Phase 1 / Phase 2 | 277 | Karyopharm Therapeutics IncINDUSTRY | 5 | Mar 19, 2025 | clinicaltrials |
| NCT02684227 | Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer | completed | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06879353 | Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery | completed | N/A | 372 | Sheikh Zayed Medical CollegeOTHER_GOV | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05910229 | Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer(RTEPROST) | completed | N/A | 120 | Groupe Hospitalier de Bretagne SudOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06559007 | Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants | completed | Phase 1 | 24 | Atridia Pty Ltd.INDUSTRY | 1 | Mar 18, 2025 | clinicaltrials |
| NCT02489903 | RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) | completed | Phase 2 | 139 | EpicentRx, Inc.INDUSTRY | 1 | Mar 17, 2025 | clinicaltrials |
| NCT03268382 | p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246 | completed | Phase 2 | 36 | Aprea TherapeuticsINDUSTRY | 3 | Mar 17, 2025 | clinicaltrials |
| NCT04318028 | An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer | completed | N/A | 20 | University of Southern CaliforniaOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT04499521 | A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer | completed | N/A | 21 | University of VirginiaOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT04832958 | Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients | completed | Phase 2 | 81 | IRCCS San RaffaeleOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT05440383 | A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia | completed | Phase 3 | 287 | Kissei Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06318182 | Testicular Self-Examination Awareness in Young Men | completed | N/A | 120 | Hitit UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT03206047 | Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2025 | clinicaltrials |
| NCT02104063 | Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET](MRI-PET) | completed | — | 78 | Queen Mary University of LondonOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT04330040 | Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer(SOLI) | completed | Phase 4 | 202 | AstraZenecaINDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT05389202 | Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate Adenoma(EMBOPERF) | completed | N/A | 45 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT05332340 | Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered | completed | Phase 1 | 12 | Biozeus Biopharmaceutical S.A.INDUSTRY | 1 | Mar 7, 2025 | clinicaltrials |
| NCT04978519 | Effectiveness of Cryotherapy Study for Prostate Cancer | completed | N/A | 16 | Chinese University of Hong KongOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT05697198 | PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine(PREFER) | completed | — | 1,429 | Labcorp Corporation of America Holdings, IncINDUSTRY | 1 | Mar 6, 2025 | clinicaltrials |
| NCT04428203 | Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | completed | Phase 1 | 21 | Zin W MyintOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT01792687 | Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate | completed | Phase 1 | 6 | Aragon Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 4, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Apr 6, 2025source: clinicaltrials